Description

3-Amino-9-[3,4-Dihydroxy-5-(Hydroxymethyl)Oxolan-2-Yl]-4,7,8,9-Tetraza Bicyclo[4.3.0]Nona-1,3,6-Trien-5-One is a complex nucleoside analog with a bicyclic heterocyclic structure, representing a high-value synthetic intermediate. This compound matters for its role in the development of novel antiviral and anticancer agents, where its unique scaffold is leveraged for targeted biological activity. It is primarily needed by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of next-generation therapeutic nucleosides and nucleotides.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel antiviral and anticancer nucleoside analogs.
• Biochemical Research: Used as a substrate or inhibitor in enzymatic studies related to nucleotide metabolism and DNA/RNA processing.
• Medicinal Chemistry: Serves as a core scaffold for structure-activity relationship (SAR) studies to optimize drug potency and selectivity.
• Precision Chemical Synthesis: Employed in the multi-step synthesis of complex, high-purity active pharmaceutical ingredients (APIs).
• Academic Research: Utilized in universities and research institutes for exploring new chemical entities and their biological interactions.

Basic Information

Product Name	3-Amino-9-[3,4-Dihydroxy-5-(Hydroxymethyl)Oxolan-2-Yl]-4,7,8,9-Tetraza Bicyclo[4.3.0]Nona-1,3,6-Trien-5-One
CAS No.	73591-56-7
Molecular Formula	C11H15N5O5
Molecular Weight	297.27 g/mol
Synonyms	9-(β-D-Ribofuranosyl)purine-2,6-diamine 3-oxide; 2,6-Diamino-9-β-D-ribofuranosylpurine 3-oxide; 9-β-D-Ribofuranosyl-2,6-diaminopurine 3-oxide; 2,6-Diaminopurine riboside 3-N-oxide; NSC 401005; 9-(β-D-Ribofuranosyl)-2,6-diaminopurine 3-oxide; 2-Amino-6-aminopurin-9-yl-β-D-ribofuranoside 3-oxide
EINECS	Contact for details

Quality Control

Our 3-Amino-9-[3,4-Dihydroxy-5-(Hydroxymethyl)Oxolan-2-Yl]-4,7,8,9-Tetraza Bicyclo[4.3.0]Nona-1,3,6-Trien-5-One is produced under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical research and development. Certificates of Analysis (COA) detailing all specifications are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container should be kept in a desiccated environment to prevent moisture uptake. For long-term storage, consider storing under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 2.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.